Philip W. Askenase
Yale University School of Medicine, CT, USA
Title: Suppressor T-cell Exosome miRNA-150 Induces APC To Release Ag/MHCpos Secondary Suppressive Exosomes, Binding TCR at the Immune Synapse to Inhibit DTH Effector T-cells
Raghu Kalluri
The University of Texas MD Anderson Cancer Center, TX, USA
Title: TBD
Kendall D. Hirschi
Baylor College of Medicine, TX, USA
Title: Impact of a Plant-Based Dietary miRNA on the Gut Microbiome
Joost J. Oppenheim
NCI/CCR, NIH
MD, USA
Title: Oncolytic Reagents may also Enhance Anti-Tumor Immunity by Inducing MyD88-dependent Maturation of Dendritic Cells
Scott K. Durum
NCI/CCR, NIH
MD, USA
Title: TBA
Guido Kroemer
Gustave Roussy Comprehensive Cancer Center, INSERM, France
Title: Overcoming a frequent inborn immune defect in breast cancer therapy
Lauren V. Wood
Chief Medical Officer, PDS Biotechnology, NJ
Title: Versamune (R-D0TAP): a Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens
Wayne Godfrey
Vice President of Clinical Development at IGM Bioscience
Title: Novel Approach to Engineering Antibody Based Immunotherapy
Eduardo Davila
University of Colorado CU Comprehensive Cancer Center, CO
Title: Novel Gene Platforms to Maintain the Persistence and Antitumor Activity of TIL-, CAR-, and DC-Based Therapies
William Hearl
Ph.D. CEO, Immunomic Therapeutics, MD
Title: UNITE Platform, A Direct Antigen Presentation Approach in Oncology
Brian Francica
Tempest Therapeutics, CA
Title: Dual Antagonism of Prostaglandin Receptors EP2 and EP4 by TPST-1495 Suppresses Tumor Growth and Stimulates Antitumor Immunity
Jing H. Wang
University of Colorado Anschutz Medical Campus, CO
Title: MHC Class-I Independent Activation of Virtual- Memory CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells
Pooja Jain
Drexel University College of Medicine, Philadelphia, PA
Title: The MAPK/ERK-regulated MEF-2 isoforms as potential new target(s) for HTLV-1 induced Adult T-cell leukemia/lymphoma (ATLL)
Jason D. Marshall
Leidos Biomedical Research, Inc., NCI Campus at Frederick, MD
Title: Performance Optimization of a Novel HPV VLP Vaccine in Mice with Novel Adjuvants
Joseph Markowitz
Moffit Cancer Center, FL
Title: Duality of NO in Melanoma
Jean Gariepy
Sunnybrook Research Institute, Toronto, Canada
Title: Development of high-valency protein-based agonists as immunomodulators
Yan Leyfmann
Penn State College of Medicine, PA
Title: Finetune Your CARs: Building the Next Generation of Anti-Cancer Therapies
Jessica E. Thaxton
Medical University of South Carolina, SC
Title: Metabolic Requirements for T Cell Protein Translation in Tumors
Theresa L. Whiteside
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, PA
Title: Tumor-Derived Exosomes and Their Role in Cancer Progression
Stephen D. Miller
Northwestern University Medical School, IL, USA
Title: Translation of a Nanoparticle-Based Delivery System for the Induction of Immune Tolerance
David Wagner
University of Colorado at Denver, CO, USA
Title: Exploring the role of CD40 in Autoimmune Inflammation: Impact on Disease
Pamela A. Guerrerio
NCI/CCR, NIH
MD, USA
Title: Tgfbr1-Mediated Defects in Squamous Epithelium Drive Local Allergic Inflammation
Warren J. Leonard
NHLBI, NIH
MD, USA
Title: TBA
Patricia Gearhart
NHLBI, NIH
MD, USA
Title: B Cells in Aging
Jacques Robert
University of Rochester Medical Center, NY
Title: Roles of Non-polymorphic MHC and innate T cells in antimycobacterial immune response and tolerance.
Immunology is one of the areas with the most cutting-edge and state of the art research going on in almost every corner of the world. This conference aims to bring together people from various areas of research and development in immunology in order to help grow and create opportunities for further advances in the field.
The program will not only include renowned keynote speakers who helped shape the turn of the century concepts in immunity and immunology but also young academicians with diverse approaches to age-old conceptions in immunology. We hope to encourage dialogue between all the attendees in order to fill in the gaps to inspire innovative collaborations in:
This Virtual Conference is a platform free of hurdles associated with: